Form D · Biotechnology
PANGIA BIOTECH, INC.
Delray Beach, FL · CIK 0002125789
Offering snapshot reported May 11, 2026 · SEC filing
- Reported sold
- $1.58M Offering amount: $1.58M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $30K Reported outside-investor minimum
- First sale
- Apr 8, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 11, 2026 | Initial | $1,580,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $168K
- Finders' fees
- $0
- Form D file number
- 021-583537
There were two closings. The first closing total amount sold was $1,030,000 including 10 investors. The second closing total amount sold was $550,000 including 8 investors. Total amount sold was $1,580,000.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| WestPark Capital, Inc. | 000039914 |
Source: Form D, filed May 11, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Frattaroli | Executive |
| Garth Lees Rolfe | Director |
| Holly Magliochetti | Director, Executive |
| Obdulio Piloto | Executive |
| Caroline Popper | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4733 West Atlantic Avenue Suite C 14
Delray Beach, FL, 33445
Delray Beach, FL, 33445